Please provide your email address to receive an email when new articles are posted on . Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth ...
The US Food and Drug Administration (FDA) on Friday proposed to reclassify non-invasive bone growth stimulators under two product codes from class III to class II, allowing the devices to be marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results